SUBSCRIBE
SUBSCRIBE

Phase 2

Why This Tiny Biotech is Giving Cash to Amgen Researchers
Drug Development
Amgen Goes on the Defensive When Critics Call Its Pipeline a Dud
June 22, 2017
 · 
2 min read
Drug Development
Vanda: Several Catalysts Coming Up
June 21, 2017
 · 
1 min read
Drug Development
While Amgen-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines
June 16, 2017
 · 
1 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Drug Development
New Data Reveals This New York Biotech’s Pipeline Could be a Game Changer
June 16, 2017
 · 
2 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Epizyme Falls as Investors Take in Disappointing Phase II Data
June 15, 2017
 · 
2 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
Why Drug Giants Like Merck & Co. and AstraZeneca PLC Scientists are Looking in the Toilet for New Cancer Treatments
June 14, 2017
 · 
2 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Business
SoCal’s Regulus Sinks After AstraZeneca PLC Bails on Lead NASH Drug
June 12, 2017
 · 
3 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
Sanofi’s Rumored Buyout Target Flexion Shows Off Mid-Stage Osteoarthritis Data
June 12, 2017
 · 
3 min read
Drug Development
How This Small Washington Biotech Stands To Outperform Rivals Amgen, Eli Lilly And Teva In Migraine Drugs
June 9, 2017
 · 
1 min read
Tiny Bay Area Biotech Wants to Rattle the Billion-Dollar Injectable Drug Markets With a Single Pill
Drug Development
Tiny Bay Area Biotech Wants to Rattle the Billion-Dollar Injectable Drug Markets With a Single Pill
June 8, 2017
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101
May 6, 2026
 · 
5 min read
Press Releases
Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
May 6, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 6, 2026
 · 
14 min read
Press Releases
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May 6, 2026
 · 
10 min read
Press Releases
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response
May 6, 2026
 · 
12 min read
Press Releases
Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week
May 6, 2026
 · 
11 min read
Press Releases
Immunocore reports first quarter 2026 financial results and provides a business update
May 6, 2026
 · 
22 min read
Press Releases
Spago Nanomedical’s Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake
May 6, 2026
 · 
3 min read
Press Releases
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
May 6, 2026
 · 
2 min read
Press Releases
Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results
May 6, 2026
 · 
14 min read
Press Releases
Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients
May 6, 2026
 · 
5 min read
Press Releases
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results
May 6, 2026
 · 
15 min read
Press Releases
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa
May 6, 2026
 · 
10 min read
Press Releases
Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting
May 6, 2026
 · 
6 min read
Press Releases
Nocion Therapeutics Announces Full Enrollment in Phase 2b ASPIRE Study of Taplucainium for Chronic Cough
May 5, 2026
 · 
3 min read
Press Releases
Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer
May 5, 2026
 · 
8 min read
Press Releases
Neuraly, Inc. Supports Phase 2 Investigator-Initiated Trial of Pegsebrenatide (NLY01) for Progressive Multiple Sclerosis
May 5, 2026
 · 
3 min read
Press Releases
Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update
May 5, 2026
 · 
19 min read
Press Releases
Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease
May 5, 2026
 · 
17 min read
Press Releases
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
May 5, 2026
 · 
8 min read
Load More